• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康日本人群中抗酒石酸酸性磷酸酶5b变异的生物学来源。

Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population.

作者信息

Kikuchi Wataru, Ichihara Kiyoshi, Mori Kazuo, Shimizu Yoshihisa

机构信息

Research and Development Headquarters, Nitto Boseki Co., Ltd, Koriyama, Japan.

Department of Clinical Laboratory Sciences, Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine, Ube, Japan.

出版信息

Ann Clin Biochem. 2021 Jul;58(4):358-367. doi: 10.1177/00045632211003941. Epub 2021 Apr 7.

DOI:10.1177/00045632211003941
PMID:33715446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8258717/
Abstract

BACKGROUND

Tartrate-resistant acid phosphatase 5b (TRACP5b) is a bone resorption marker that is mainly used in clinical management of osteoporosis. For proper interpretations of test results for serum TRACP5b, we explored their biological sources of variation, esp. age-related changes, and associations with other bone-related markers in healthy Japanese adults.

METHODS

During the 2009 East-Southeast Asian multicentre study for determination of reference intervals, 72 major laboratory tests were measured by centralized assays in 3541 well-defined healthy volunteers. The current study included 1980 test results in Japanese subjects for five bone-related markers: TRACP5b, bone alkaline phosphatase, intact parathyroid hormone, calcium and inorganic phosphate. Information on sources of variation, including body mass index, smoking habits and ABO-blood group, were obtained from a health status questionnaire.

RESULTS

Gender-specific profiles of age-related changes were observed for each parameter. Increased values starting from 40 years of age in females were most prominent for TRACP5b, followed by bone alkaline phosphatase and inorganic phosphate. TRACP5b in males decreased with body mass index, bone alkaline phosphatase and TRACP5b were higher in blood type-O subjects, especially in males. TRACPT5b was closely correlated with bone alkaline phosphatase, and moderately correlated with adjusted calcium and inorganic phosphate, especially in females aged ≥45 years. Reference intervals for each analyte were determined parametrically based on gender and age.

CONCLUSIONS

This study elucidated sources of variation of TRACP5b and related bone markers in healthy Japanese subjects and demonstrated a specific age profile for each marker. These results are of relevance for better clinical usage and interpretations of serum levels of bone markers.

摘要

背景

抗酒石酸酸性磷酸酶5b(TRACP5b)是一种骨吸收标志物,主要用于骨质疏松症的临床管理。为了正确解读血清TRACP5b的检测结果,我们探讨了其生物学变异来源,特别是与年龄相关的变化,以及与健康日本成年人其他骨相关标志物的关联。

方法

在2009年东亚 - 东南亚多中心参考区间测定研究中,对3541名明确界定的健康志愿者进行集中检测,测量了72项主要实验室指标。本研究纳入了1980例日本受试者的5种骨相关标志物的检测结果:TRACP5b、骨碱性磷酸酶、完整甲状旁腺激素、钙和无机磷。通过健康状况问卷获取包括体重指数、吸烟习惯和ABO血型等变异来源的信息。

结果

观察到每个参数与年龄相关变化的性别特异性特征。女性从40岁开始数值升高,这在TRACP5b中最为明显,其次是骨碱性磷酸酶和无机磷。男性的TRACP5b随体重指数降低,O型血受试者的骨碱性磷酸酶和TRACP5b较高,尤其是男性。TRACPT5b与骨碱性磷酸酶密切相关,与校正后的钙和无机磷中度相关,尤其是在年龄≥45岁的女性中。基于性别和年龄参数确定了每种分析物的参考区间。

结论

本研究阐明了健康日本受试者中TRACP5b及相关骨标志物的变异来源,并展示了每种标志物的特定年龄特征。这些结果对于更好地临床应用和解读骨标志物血清水平具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21df/8258717/359604345cc9/10.1177_00045632211003941-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21df/8258717/99ca1f4d6959/10.1177_00045632211003941-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21df/8258717/359604345cc9/10.1177_00045632211003941-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21df/8258717/99ca1f4d6959/10.1177_00045632211003941-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21df/8258717/359604345cc9/10.1177_00045632211003941-fig2.jpg

相似文献

1
Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population.健康日本人群中抗酒石酸酸性磷酸酶5b变异的生物学来源。
Ann Clin Biochem. 2021 Jul;58(4):358-367. doi: 10.1177/00045632211003941. Epub 2021 Apr 7.
2
The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.血清耐酒石酸酸性磷酸酶 5b 在评估腹膜透析患者骨吸收中的临床应用。
Clin Endocrinol (Oxf). 2013 Jun;78(6):844-51. doi: 10.1111/cen.12070. Epub 2013 Apr 6.
3
Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.抗酒石酸酸性磷酸酶 5b 同工酶在评估骨质疏松症治疗反应中的应用有限。
Ir J Med Sci. 2014 Mar;183(1):47-52. doi: 10.1007/s11845-013-0970-6. Epub 2013 Jun 5.
4
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.血清抗酒石酸酸性磷酸酶(TRACP5b)作为慢性肾脏病患者骨吸收标志物的效用:不受肾功能障碍影响。
Clin Endocrinol (Oxf). 2008 Aug;69(2):189-96. doi: 10.1111/j.1365-2265.2008.03187.x. Epub 2008 Jan 23.
5
Diagnostic value of TRACP5b expression in patients with bone tumors.TRACP5b 表达在骨肿瘤患者中的诊断价值。
J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2):557-562.
6
Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.抗酒石酸酸性磷酸酶5b活性是监测乳腺癌患者治疗后骨转移的一种有用的骨标志物。
Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):424-8. doi: 10.1158/1055-9965.EPI-04-0842.
7
Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.中国女性血清抗酒石酸酸性磷酸酶5b的年龄相关变化及其与骨密度的关系
Acta Pharmacol Sin. 2008 Dec;29(12):1493-8. doi: 10.1111/j.1745-7254.2008.00890.x.
8
Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.骨化三醇对继发性甲状旁腺功能亢进中5b型抗酒石酸酸性磷酸酶和白细胞介素-6的影响。
Blood Purif. 2006;24(5-6):423-30. doi: 10.1159/000094899. Epub 2006 Aug 4.
9
The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone.抗酒石酸酸性磷酸酶 5b 同工酶在骨巨细胞瘤中的诊断和预后价值。
Int J Clin Oncol. 2024 Sep;29(9):1391-1397. doi: 10.1007/s10147-024-02557-5. Epub 2024 Jul 12.
10
Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase.成纤维细胞生长因子 23 的 C 端片段、硬骨素、骨碱性磷酸酶同工酶 5b 和抗酒石酸酸性磷酸酶 5b 的儿科参考值。
Ann Clin Biochem. 2012 Nov;49(Pt 6):546-53. doi: 10.1258/acb.2012.011274. Epub 2012 Sep 14.

引用本文的文献

1
Gender, clinical phenotype and imaging features of patients with late-onset psoriatic arthritis.迟发性银屑病关节炎患者的性别、临床表型及影像学特征
Clin Rheumatol. 2025 May 30. doi: 10.1007/s10067-025-07462-4.
2
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).骨转换标志物在骨质疏松症诊断和管理中的作用更新:来自欧洲骨质疏松症、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)、国际骨质疏松症基金会(IOF)以及国际临床化学和检验医学联合会(IFCC)的共识文件。
Osteoporos Int. 2025 Apr;36(4):579-608. doi: 10.1007/s00198-025-07422-3. Epub 2025 Mar 28.
3

本文引用的文献

1
Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition).日本骨质疏松症学会骨转换标志物在骨质疏松症诊治中的应用指南(2018 年版)概要
Clin Chim Acta. 2019 Nov;498:101-107. doi: 10.1016/j.cca.2019.08.012. Epub 2019 Aug 16.
2
Coupling of bone resorption and formation by RANKL reverse signalling.RANKL 反向信号转导耦联骨吸收与形成。
Nature. 2018 Sep;561(7722):195-200. doi: 10.1038/s41586-018-0482-7. Epub 2018 Sep 5.
3
Obesity and bone metabolism.
Dairy consumption, bone turnover biomarkers, and osteo sono assessment index in Japanese adults: A cross-sectional analysis of data from the Iwaki Health Promotion Project.日本成年人的乳制品摄入量、骨转换生物标志物与骨超声评估指数:岩城健康促进项目数据的横断面分析
Bone Rep. 2024 Apr 29;21:101770. doi: 10.1016/j.bonr.2024.101770. eCollection 2024 Jun.
4
Discordant responses of bone formation and absorption markers in Japanese infants with vitamin D deficiency: a comprehensive matched case-control study.日本维生素D缺乏婴儿骨形成和吸收标志物的不一致反应:一项全面的配对病例对照研究。
JBMR Plus. 2024 Mar 18;8(5):ziae033. doi: 10.1093/jbmrpl/ziae033. eCollection 2024 May.
5
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer.骨转换标志物、I型前胶原氨基端前肽和抗酒石酸酸性磷酸酶5b用于预测前列腺癌去势抵抗性
Biomedicines. 2024 Jan 26;12(2):292. doi: 10.3390/biomedicines12020292.
6
Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction.用于前列腺癌骨转移检测与预测的生物标志物
J Pers Med. 2023 Apr 22;13(5):705. doi: 10.3390/jpm13050705.
7
Biomarkers of aging.衰老的生物标志物。
Sci China Life Sci. 2023 May;66(5):893-1066. doi: 10.1007/s11427-023-2305-0. Epub 2023 Apr 11.
肥胖与骨代谢。
Hormones (Athens). 2018 Jun;17(2):205-217. doi: 10.1007/s42000-018-0018-4. Epub 2018 Apr 24.
4
Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment.骨质疏松症治疗期间使用地诺单抗时需要维生素D和钙。
Bone Res. 2017 Oct 10;5:17021. doi: 10.1038/boneres.2017.21. eCollection 2017.
5
Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.骨转换标志物在代谢性骨病诊断和监测中的应用
Clin Chem. 2017 Feb;63(2):464-474. doi: 10.1373/clinchem.2016.259085. Epub 2016 Dec 9.
6
A global multicenter study on reference values: 1. Assessment of methods for derivation and comparison of reference intervals.一项关于参考值的全球多中心研究:1. 参考区间推导与比较方法的评估
Clin Chim Acta. 2017 Apr;467:70-82. doi: 10.1016/j.cca.2016.09.016. Epub 2016 Sep 22.
7
Clinical usefulness of bone turnover marker concentrations in osteoporosis.骨转换标志物浓度在骨质疏松症中的临床应用价值
Clin Chim Acta. 2017 Apr;467:34-41. doi: 10.1016/j.cca.2016.06.036. Epub 2016 Jun 30.
8
A RANKL Wrinkle: Denosumab-Induced Hypocalcemia.RANKL的一个问题:地诺单抗诱导的低钙血症。
J Med Toxicol. 2016 Sep;12(3):305-8. doi: 10.1007/s13181-016-0543-y. Epub 2016 Mar 17.
9
Sources of variation analysis and derivation of reference intervals for ALP, LDH, and amylase isozymes using sera from the Asian multicenter study on reference values.使用亚洲多中心参考值研究中的血清进行碱性磷酸酶、乳酸脱氢酶和淀粉酶同工酶的变异来源分析及参考区间推导。
Clin Chim Acta. 2015 Jun 15;446:64-72. doi: 10.1016/j.cca.2015.03.034. Epub 2015 Apr 2.
10
Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.雌激素通过调节RANKL膜结合来拮抗RUNX2介导的成骨细胞驱动的破骨细胞生成。
Bone. 2015 Jun;75:96-104. doi: 10.1016/j.bone.2015.02.007. Epub 2015 Feb 17.